MARKET WRAP: Rand weaker as vaccine euphoria fades

The rand gave back all of Monday’s gains on Tuesday as the euphoria over a possible coronavirus vaccine faded, with investors now cautious about the details regarding its preparation and distribution.

On Monday, news emerged that a vaccine developed by US pharmaceutical giant Pfizer in partnership with BioNTech was showing good results in the testing phase.